Physician profile
James French
NPI 1821007394
$2,196.47
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $841 · 2022: $15.46.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $380.00 | 2019-2020 | |
| Amgen INC. | $314.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $238.88 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $214.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $133.57 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.56 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $101.86 | 2019-2020 | |
| Abbvie INC. | $95.45 | 2019-2020 | |
| Novo Nordisk INC | $90.53 | 2019-2020 | |
| Amarin Pharma, INC. | $84.23 | 2019-2020 | |
| Akcea Therapeutics, INC. | $69.67 | 2019 | |
| Esperion Therapeutics, INC. | $51.24 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.75 | 2019-2020 | |
| Vertiflex, INC. | $43.55 | 2019 | |
| Sanofi Pasteur INC. | $30.18 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $28.24 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.19 | 2020 | |
| Tepha INC | $25.06 | 2019 | |
| Amicus Therapeutics, INC. | $24.22 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.85 | 2019 | |
| Glaxosmithkline, LLC. | $17.13 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James French listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.